Skip to main content
Future Journal of Pharmaceutical Sciences
Download PDF

Identification of validated substitute for Asoka (Saraca asoca (Roxb.) Willd.) by phytochemical and pharmacological evaluations

Future Journal of Pharmaceutical Sciences volume 6, Article number: 10 (2020) Cite this article

Abstract

Background

Asoka is an important drug used in many Ayurvedic formulations. The bark of Saraca asoca (Roxb.) Willd. is the genuine source plant for Asoka. Due to diminishing availability and increasing requirement, the Ayurvedic industry is facing acute shortage of this crude drug. It is usual that traders try to deceive the consumers by tendering similar bark of other trees. The unscientific substitution may affect the quality of herbal preparations adversely. The aim of the present study is to identify a scientifically validated substitute for Asoka.

Results

Phytochemical and pharmacological evaluation has been carried out using plant parts of four medicinal plants viz, Saraca asoca (AB), Polyalthia longifolia (PB), Shorea robusta (SB), and Trema orientalis (TB). The results of the study showed that among the tested extracts, AB and SB showed significant dose-dependent protection against bilateral ovariectomy-induced changes in estrus cycle, uterus weights, and lipid profile. LC/MS analysis revealed the presence of active catechins in both AB and SB. Polyalthia longifolia, the common adulterant of Asoka, showed entirely different chemical and biological properties.

Conclusion

This study concluded the possibility of using S. robusta bark as substitute for Asoka.

Graphical abstract

Background

In Ayurveda, Asoka is used for the treatment of excessive uterine bleeding, gynecological problems, stomach ache, leucorrhoea, menstrual irregularities, internal piles, diabetes, dyspepsia, indigestion, burning sensation, blood disorders, fractures, tumors, bites, ulcerations, skin discoloration, etc. [1]. The bark of Saraca asoca (Roxb.) Willd. (Leguminosae) is the genuine source plant for Asoka. It is found throughout India, especially in Himalaya, Kerala, Bengal, and the whole south region [2].

Ayurvedic texts describe more than 50 preparations of Asoka for the treatment of a variety of ailments in which stem bark of S. asoca is used as one of the main ingredients. The bark is also useful in treating scorpion-sting and internal piles [3].

The well-known Ayurvedic medicines “Ashokarishta” and “Ashokaghrita” are prepared with S. asoca bark as the primary raw material. A difficulty in the commercial cultivation of S. asoca is its inherent slow growth rate and poor yield of bark. Due to dwindling availability and increasing requirement, the Ayurvedic industry is facing acute shortage of this crude drug. The original material has become scarce and the market item is often admixed with bark of other trees which pass off as Asoka bark. It is usual that traders try to deceive the consumers by tendering similar bark of other trees. Since these unauthentic materials do not possess the pharmacological effects of Asoka, the drugs prepared using them are liable to be non-effective, if not harmful. The most widely used adulterant is the bark of Polyalthia longifolia which is known as “False Asoka” [4, 5].

The aim of the present study was to find out a substitute for bark of S. asoca by evaluating the phytochemistry and pharmacology of its stem and root of other species such as Polyalthia longifolia, Shorea robusta, and Trema orientalis.

Methods

Chemicals and reagents

Folin-Ciocalteu reagent was procured from Sisco Research Laboratory (SRL), Mumbai, India. LC/MS grade solvents and analytical standards such as gallic acid and quercetin were procured from Sigma Chemicals Co. (Bangalore, India). All other chemicals employed were of standard analytical grade from Merck India.

Collection of plant materials

Plants such as S. asoca, P. longifolia and T. orientalis were collected from Herb garden of the Centre. The bark of S. robusta was collected from Chhattisgarh. All the materials were authenticated by Plant Systematics and Genetic Resources division of the Centre, and herbarium specimens were deposited in CMPR Herbarium (CMPR 11252, CMPR 11253, CMPR 11251, and CMPR 11255)

Extraction of materials

The plant materials were shade dried and pulverized. Five grams each of the sample was successively extracted with various solvents like n-hexane, chloroform, and methanol by refluxing for 6 h. Crude extracts were prepared separately with methanol, water, and hydroalcohol (ethanol:water 50:50) using reflux extraction method. The process was repeated in triplicates. The final extracts were pooled and concentrated at 40 °C using a Rotary evaporator (Heidolph, Germany) and it was made up to 100 ml with respective solvents in standard flasks. The extracts were kept under refrigeration for various phytochemical analyses.

Estimation of total polyphenolics

The total phenolic content (TPC) was determined using Folin-Ciocalteu reagent [6, 7]. TPC was expressed as gallic acid equivalents (GAE) in mg/g of the sample.

Estimation of total catechins

Catechins and other flavonoids were isolated by overnight shaking at 70 °C in incubator shaker. Twenty grams of powdered materials was macerated with 200 ml of methanol and kept for overnight shaking at 250 rpm. The residue was concentrated to dryness under reduced pressure in rotary evaporator (Heidolph, Germany) and it was redissolved in LC/MS grade methanol.

Estimation of total catechins was carried out using diazotized sulfanilamide as reported previously [8]. The absorbance of the samples and standards was measured at 425 nm using spectrophotometer (Shimadzu, Japan) against reagent blank. The concentration of catechins in the sample extract was estimated from standard curve of catechin.

High-performance thin-layer chromatographic (HPTLC) analysis

HPTLC analysis was performed using CAMAG HPTLC system (Switzerland). Samples were applied using automatic sample applicator, CAMAG ATS-4 on aluminum-backed pre-coated silica gel 60F254 TLC plate (Merck, India). Mobile phase was standardized as toluene, ethyl acetate in the ratio of 8:2. The chromatogram was developed in a saturated Twin Trough chromatographic chamber (Camag, Switzerland). The developed plate was visualized under UV at 254 nm and 366 nm and in visible light after derivatizing with anisaldehyde-sulphuric acid reagent followed by heating at 105 °C for 5 min.

High-performance liquid chromatography (HPLC) analysis

Comparative HPLC profiling was done using Shimadzu High-Performance Liquid Chromatographic system equipped with LC-10ATVP pump, SPD M10AVP Photo Diode Array Detector in combination with CLASS-VP 6.12 SP5 integration software. The mobile phase used for the separation was HPLC grade methanol (A) and 0.1% formic acid in water (B) in a gradient elution, with % B at 0.01–65, 5–50, 8–40, 12–30, 15–20, 18–10, 23–30, 25–40, 28–50, and 30–60. The column used was Merck HIBAR Lichrospher RP 18e (5 μm) with a Phenomenex guard column (4 mm × 2 mm i.d, 5 μm). The samples were injected using a 20-μl loop (Rheodyne Rohnet Park, CA, USA). The flow rate was maintained at 0.8 ml/min. The PDA signal was recorded at 360 nm.

LC/MS characterization of catechin fractions

LC-ESI/MS analysis of catechin fraction was conducted on Agilent 6520 accurate mass Q-TOF LC/MS coupled with Agilent LC 1200 equipped with Extend-C18 column of 1.8 μm, 2.1 × 50 mm. Gradient elution was performed with LC/MS grade acetonitrile (A) and 0.1% acetic acid in methanol (B) at a constant flow rate of 0.7 ml/min, with an increase in the volume of B %: 5–20%, 12–30%, 19–40%, 26–50%, and 30–40%. The MS analysis was performed using ESI in negative mode with the following conditions: drying gas (nitrogen) flow 5 L/min, nebulizer pressure 40 psig, drying gas temperature 325 °C, capillary voltage + 3000 V, fragmentor volt 125 V, and Oct RF Vpp 750 V. The mass fragmentation was performed with varying collision energy 4 V/100 DA with an offset of 8 V.

Acute oral toxicity studies of plant extracts

Two hundred and fifty grams of various samples such as S. asoca bark, S. asoca stem, P. longifolia bark, S. robusta bark, and T. orientalis bark were extracted with water using soxhlet extraction method for 72 h. The final extracts were concentrated to dryness under reduced pressure using rotary evaporator (Heidolph, Germany).

The experiment was conducted on Wistar rats (females) weighing 147 to 204 g and aged 8 to 9 weeks obtained from the Animal House, J.S.S. College of Pharmacy, Ootacamund, Tamil Nadu, India. The rats were distributed into 5 groups with 6 animals in each group. The experimental procedures relating to the animals were authorized by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) (approval no. JSSCP/IAEC/OT/Ph.D/Ph.Cology/06/2017-18) before starting the study and were conducted under the internationally accepted principles for laboratory animal use and care [9].

The extracts were prepared from a plant material having a high safety margin, and hence it was decided to use 2000 mg/kg (limit test) for this study. The test item was prepared immediately prior to administration on respective treatment days. A quantity of 2 g of the test item was dissolved in distilled water and the volume was made up to 10 ml to get a test item concentration of 200 mg/ml. Homogeneity of the test item in the vehicle was maintained during treatment by constant stirring and mixing. The test substance was administered soon after preparation.

The prepared test item solutions were administered once orally as gavage to the fasted (16-18 h) rats at the dose volume of 10 ml/kg b.wt. to deliver a dose of 2000 mg/kg b.wt. Food was offered about 3–4 h after dosing. Water was not withheld.

The treated rats were observed five times during day 1 (day of administration) i.e., at 30 min and four times hourly (post-administration) intervals and once daily, and thereafter for a total of 14 days. The clinical signs were recorded on all working days. The body weights of rats were recorded on test day 1 (pre-administration), day 8 (7 days post-administration), and day 15 (14 days post-administration). The rats were euthanized by using diethyl ether anesthesia and necropsied.

Evaluation of estrogenic activity

The samples, Saraca asoca bark (AB), Saraca asoca stem (AS), Polyalthia longifolia bark (PB), Shorea robusta bark (SB), and Trema orientalis bark (TB), were studied for their estrogenic activity in ovariectomized Wistar rats [10].

The experiment was conducted on 72 numbers of Wistar rats (females) weighing 64 to 99 g and aged 4 weeks obtained from the Animal House, J.S.S. College of Pharmacy, Ootacamund, Tamil Nadu, India . The rats were distributed into 5 groups with 6 animals in each group. The experimental procedures relating to the animals were authorized by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) (JSSCP/IAEC/OT/Ph.D/Ph.Cology/05/2017-18) before starting the study and were conducted under the internationally accepted principles for laboratory animal use and care.

Animals were divided into 12 groups of 6 each.

  1. I.

    Groups 1 and 2 served as sham and control, respectively, and received distilled water (10 ml/kg., p.o.).

  2. II.

    Groups 3 and 4 received AB extract at a dose of 200 and 400 mg/kg, p.o., respectively.

  3. III.

    Groups 5 and 6 received AS extract at a dose of 200 and 400 mg/kg., p.o., respectively.

  4. IV.

    Groups 7 and 8 received PB extract at a dose of 200 and 400 mg/kg., p.o., respectively.

  5. V.

    Groups 9 and 10 received SB extract at a dose of 200 and 400 mg/kg., p.o., respectively.

  6. VI.

    Groups 11 and 12 received TB extract at a dose of 200 and 400 mg/kg., p.o., respectively.

Bilateral ovariectomy was performed in all the groups, except sham group via dorsolateral approach under general anesthesia. In sham group animals, only placebo surgery was performed. After 1 week of recovery, animals were given respective treatments for a period of 8 weeks. The estrogenic activity of the test items was assessed by analyzing the estrus cycle, uterine weight, uterine glycogen content, serum lipid profile, and histopathology of the uterus.

Estimation of uterine glycogen content

Uterine tissue (15 mg) was homogenized in 20 ml 30% KOH, and heated at 100 °C for 30 min, to inactivate enzymes and destroy free glucose. To isolate glycogen, samples was diluted with 1.2 vol 95% ethanol, frozen at − 80 °C for 60 min, then thawed and centrifuged at 9600×g for 10 min. The supernatant was discarded and the pellets dried overnight. To breakdown glycogen to glucose, 100 μl 1.0 N HCl was added to each tube and heated at 90–100 °C for 2.5 h. Glucose concentrations was measured by using Glucose Assay Kit (120235, M/s. Erba Mannheim, Transasia Biomedicals Ltd. Solan, HP, India). The percentage of glycogen is calculated using the standard formula.

Estimation of lipid profile

The blood sample collected was allowed to clot for 45 min at room temperature. The serum was separated by centrifugation at 3000 rpm at 30 °C for 15 min and used for assaying total cholesterol, triglycerides, HDL, and total protein using Precision Biomed assay kits.

Histopathological studies

The uterus tissue was fixed in the 10% formalin, dehydrated in gradual ethanol (50–100%), cleared in xylene, and embedded in paraffin wax. The sections, with 5–6 μm thickness, were then prepared using rotary microtome and stained with hematoxylin and eosin dye for microscopic observation of histopathological changes in the uterus.

Statistical analysis

For determination of significant intergroup differences of each parameter, one-way analysis of variance (ANOVA) was carried out. Dunnett’s test was used for individual comparisons after significant ANOVA results. The differences with p < 0.05 were considered statistically significant. Graphpad Prism-6 software (Graphpad Software Inc., USA) was used for the statistical analysis.

Results

Estimation of total catechins

Total catechins were estimated using spectrophotometric method with diazotized sulfanilamide. The bark of S. asoca showed the highest catechin content (21.62) followed by T. orientalis (16.46). The catechin contents of other samples are much lower while comparing with the bark of S. asoca, which is the genuine drug.

Estimation of total phenolic content (TPC)

Total phenolic content (TPC) of selected species was estimated for different extracts such as methanol, water, and hydroalcohol. TPC was calculated from calibration curve of gallic acid (R2 = 0.992). TPC of various species are presented as Fig. 1. Highest TPC was showed by T. orientalis for all the extracts. Hydroalcoholic extract of T. orientalis provided 113.11 mg equivalent of phenolics. Phenolic contents of bark of S. asoca are 78.66, 47.77, and 102.11 for methanol, water, and hydroalcohol, respectively. Phenolic content of S. asoca stem is much lower than that of its bark.

Fig. 1
figure 1

Total phenolics of selected species

Full size image

HPTLC profiling

Thin-layer chromatography is a rapid and reliable technique for phytochemical comparison. HPTLC provides advancement such as spectral evaluation, digital documentation, and densitometry scanning for proper chemical comparison of various compounds separated with different chromospheres. Comparative HPTLC profiles were developed for various extracts like n-hexane and chloroform (Fig. 2). TLC profile of hexane extracts, at 366 nm a common band with Rf 0.48 was observed in all the species. Compound at Rf 0.08 (blue) is common for AB, AS, and PB. A blue band at 0.11 (blue) was found to be present in AB and AS. A band at 0.88 (blue) is present in Polyalthia bark only. At 254 nm, a common band at Rf 0.54 is present in all the selected species. Bands at Rf 0.08 and 0.12 were observed in AB, AS, PB, and TB. Common band at Rf 0.24 were found in PB and SB. A common band at Rf 0.39 was noted in PB and TB. A single band at Rf 0.7 is observed in PB, a band at Rf 0.78 was observed in SB and Rf 0.84 in PB.

Fig. 2
figure 2

HPTLC profiling of n-hexane and chloroform extracts of selected species, (1–5, n-hexane extracts; 6-10 Chloroform extracts)

Full size image

Tracks: AB, AS, PB, SB, and TB

TLC profile of chloroform extracts at 366 nm, common bands at Rf 0.47 (fluorescent blue), 0.54 (red), and 0.87 (dark blue) were observed in all the species. Band at Rf 0.04 (fluorescent blue) is common for three species AB, AS, and PB. A band at 0.09 (fluorescent blue) was found in SB, 0.13 (blue) in PB and 0.15 (blue) in Asoka bark. At 254 nm, a band at Rf 0.05 is observed in AB, PB, and SB. A common band at Rf 0.54 was observed in AS, PB, and SB. A band at Rf 0.04 was visible only in AB. Bands at Rf 0.26, 0.38, and 0.7 were observed only in PB.

HPLC analysis

HPLC profiling of bark extracts of four selected species along with stem extract of S. asoca was done using reverse phase chromatographic conditions. Retention time (tR) was recorded at 360 nm. Both the bark and stem of S. asoca showed some common peaks at tR 3.6, 16.1, 18.1 and 19.9. Most of the similar compounds separated were confirmed by comparing the retention time and online UV spectra. Two major peaks with comparatively higher peak area percentage at 16.3 and 19.3 were observed for S. asoca stem. All the other species selected have less similarity when compared to the genuine source plant part (Fig. 3a, b).

Fig. 3
figure 3

HPLC chromatogram of selected species. a Overlaid chromatogram of selected barks. b Overlaid HPLC chromatogram of bark and stem of S. asoca

Full size image

HPLC analyses concluded that the different species selected are not comparable with the genuine drug in terms of phytochemicals separated. However, S. asoca bark showed a few similar phytochemicals with that of its stem.

LC/MS analysis of catechin fractions

The fractions were subjected to LC/MS analysis for detailed characterization. LC/MS analysis was done in ESI negative mode in order to obtain maximum ionization. Total ion chromatogram (TIC) obtained for MS analysis was extracted to Base Peak Chromatogram (BPC) and integrated to record all the molecular ion peaks. The molecular ions with different [M-H] values were evaluated and further characterization was carried out by MS/MS analysis. On MS/MS analysis, molecular ions were fragmented on collision-induced dissociation (CID). The tentative structure was assigned based on MS/MS fragments obtained for each [M-H] value (Table 1, Fig. 4). Catechins such Catechin (C), Epicatechin (EC), Epicatechin-3 gallate (ECG), Gallo catechin (GC) and Gallocatechin-3-gallate (GCG) were identified from the bark of S. asoca and the bark of S. robusta. Catechin, Epicatechin, and gallo catechin were found in the stem of S. asoca and the bark of T. orientalis. Catechins were not identified in the bark of P. longifolia.

Table 1 LC-MS/MS analysis of catechin fraction of selected species
Full size table
Fig. 4
figure 4

LC-ESI-MS/MS analysis of Catechin fractions

Full size image

Evaluation of acute oral toxicity

The acute oral toxicity of various extracts such as AB, AS, SB, and TB were evaluated in Wistar rats. There were no toxic signs and pre-terminal deaths. All the rats gained weight through the observation period. At the end of the observation period, the rats were sacrificed using diethyl ether anesthesia and subjected to detailed necropsy and no abnormality was detected.

Based on the results of the acute oral toxicity (Acute Toxic Class Method) of the test extracts Wistar rats, the LD50 of the test item may be classified as GHS category 5 (LD 50 > 2000 mg/kg) as per OECD guideline no. 423, December 2001, and it is protective in nature [15].

Evaluation of estrogenic activity

The results of the study showed that bilateral ovariectomy has produced a significant decrease in uterine weight, uterine glycogen content, and epithelial thinning and endometrial atrophy of the uterus. In addition, a significant decrease in serum HDL levels and a significant increase in serum total cholesterol and triglyceride levels, which also had an acyclic effect on the estrus cycle, were observed in group 2, control animals when compared to group 1, sham-operated animals (p < 0.05). Among the test item treated groups, groups 3 and 4 treated with AB extract and groups 9 and 10 treated with SB extract show a significant dose-dependent protection against bilateral ovariectomy-induced changes (p < 0.05). The results of the study, therefore, conclude that among the extracts tested, AB and SB extracts show significant estrogenic activity under the testing conditions and the model employed.

Effect of test items on body weight

No significant difference in the body weights was observed with the treated groups (Table 2) when compared to control group (p > 0.05).

Table 2 Effect of test items on weekly body weight of rats
Full size table

Effect of test items on uterine weight

Bilateral ovariectomy produced a significant decrease in uterine weights (Table 3) in group 2 control when compared to group 1 sham (p < 0.05). Groups 3 and 4 treated with AB extract and groups 9 and 10 treated with SB extract show a significant dose-dependent protection against bilateral ovariectomy-induced changes in uterine weights (p < 0.05). In addition, Group 6 animals treated with high dose of AS extract also show a significant protection (p < 0.05).

Table 3 Effect of test items on uterus weight, on uterine glycogen levels, and on serum lipid profile
Full size table

Effect of test items on uterine glycogen content

Bilateral ovariectomy produced a significant decrease in uterine glycogen content (Table 3) in group 2 control when compared to group 1 sham (p < 0.05). Groups 3 and 4 treated with AB a non-significant protection against bilateral ovariectomy-induced changes in uterine glycogen content (p > 0.05). Other treated groups show no protection against the ovariectomy-induced changes in uterine glycogen content (p > 0.05).

Effect of test items on serum lipid profile

Bilateral ovariectomy produced a significant increase in serum total cholesterol and triglyceride levels and significantly decreased serum HDL levels in group 2 control when compared to group 1 sham (p < 0.05). Among the treated groups, only high doses of AB, AS, and SB extracts show significant protection against the ovariectomy-induced changes in serum lipid profile (Table 3).

Effect of test items on estrus cycle

Bilateral ovariectomy produced arrest of estrus cycle at diestrous phase in Group 2 control when compared to Group 1 sham. Groups 3 and 4 treated with AB extract and groups 9 and 10 treated with SB extract significantly restore the acyclic effect of bilateral ovariectomy. Other treatment shows no or minimal effects against bilateral ovariectomy-induced acyclic effects.

Effect of test items on histopathology of uterus

Sham-operated animals (group 1) showed normal architecture of the uterus. Ovariectomized animals (group 2) showed severe degree of atrophy of uterus characterized by extensive areas of epithelial thinning and atrophy of endometrial glands. Groups 3 and 4 treated with AB extract and groups 9 and 10 treated with SB extract show a moderate degree of restoration of epithelial thinning and atrophy of endometrial glands. The other treated groups show either minimal or no protection against bilateral ovariectomy-induced changes (Fig. 5).

Fig. 5
figure 5

Histopathology of the uterus of the normal, control, and treated group

Full size image

Discussion

According to the National Medicinal Plant Board, Ministry of AYUSH, Government of India, New Delhi, domestic demand of Asoka bark is more than 100 metric tons per year. The available cultivation never fulfilled the commercial demands earlier nor can they do so in near future. The plant is red listed in vulnerable category and is reported to be endangered. Identification of a scientifically validated substitute for the bark of Saraca asoca is an urgent need of Ayurvedic industry [16, 17]. The purpose of this study was to identify a scientifically validated alternative source for Asoka.

The bark of S. asoca is a rich source for many polyphenolic components. The estimation of major phenolics such as total phenolics, total flavonoids, and total catechins were estimated spectrophotometrically by various methods. The phenolic profiling of selected barks showed that S. asoca and T. orientalis contain higher amount of polyphenolics and it is in agreement with the previous reports [18, 19]. The bark of Shorea robusta also showed comparatively higher phenolic content. Variation was also noticed with respect to the nature of the solvent used for extraction. The highest values were observed for hydroalcoholic extracts and this might be due to the optimum polarity of the alcohol-water combination for extracting maximum phenolic compounds [20].

Catechin estimation showed that the bark of S. asoca contains the highest catechins compared all other barks. It was also noticed that the catechin content of the stem of S. asoca is very low. Catechins are naturally occurring flavonols and well-demonstrated phytochemicals having a variety of pharmacological properties [8]. Specific catechins from various barks used were also identified by tandem mass spectroscopic analysis. LC/MS analysis showed that catechins such as Catechin, Epicatechin, Epicatechin-3 gallate, Gallo catechin, and Gallocatechin-3-gallate were found to be present in barks of both S. asoca and S. robusta. Estrogenic activity of catechins and isoflavones are well established [21, 22].

In Ayurveda, Asoka is primarily used for the management of female reproductive problems. The estrogenic activity of Asoka was evaluated in comparison with other selected bark drugs. The study concluded that both S. asoca and S. robusta showed significant estrogenic activity in experimental animals.

Conclusion

Phytochemical and pharmacological evaluation has been carried out using plant parts of four medicinal plants viz, S. asoca, P. longifolia, S. robusta and T. orientalis to find out the substitute for Asoka. On the basis of overall evaluation, the possibility of using bark of Shorea robusta as a substitute for Asoka is suggested for further studies. The present study also revealed that the bark of P. longifolia which is the common adulterant in the trading of Asoka bark has entirely different chemical and biological properties and hence the adulteration of Asoka with P. longifolia will adversely affect the quality of finished formulations.

Availability of data and materials

All data and material are available upon request.

Abbreviations

AB:

Saraca asoca bark

AS:

Saraca asoca stem

PB:

Polyalthia longifolia bark

SB:

Shorea robusta bark

TB:

Trema orientalis bark

LC-MS/MS:

Liquid chromatography mass spectroscopy

HPTLC:

High-performance thin-layer chromatography

References

  1. Sivarajan VV, Balachandran I (1994) Ayurvedic drugs and their plant sources. Oxford & IBH Publishing Co. Pvt. LTD, New Delhi, pp 57–59

    Google Scholar 

  2. Udayan PS, Balachandran I (2009) Medicinal Plants of Arya Vaidya Sala Herb garden. Arya Vaidya Sala Kottakkal 529

  3. Rathee P, Rathee S, Rathee D, Rathee D, Kalia AN (2010) In vitro antioxidant studies and total phenolic content of Ficus religiosa fruits extract. Pharmacologyonline 2:737–737

    Google Scholar 

  4. Warrier PK, Nambiar VPK, Ramankutty C (1996) Indian medicinal plants: a compendium of 500 species, vol 5, p 592

    Google Scholar 

  5. Begum SN, Ravikumar K, Ved DK (2014) Asoka’ – an important medicinal plant, its market scenario and conservation measures in India. Curr Sci 107:26–28

    Google Scholar 

  6. Singleton VL, Rossi JA Jr (1965) Colorimetry of total phenolics with phosphomolybdic phosphotungstic acid reagents. Am J Eno Viticulture 16:144–158

    CAS  Google Scholar 

  7. Sulaiman CT, Thushar KV, George S, Balachandran I (2014) Phenolic characterization of selected Salacia species using LC-ESI-MS/MS analysis. Nat Prod Res 28:1021–1024

    Article  CAS  Google Scholar 

  8. Singh HP, Ravindranath SD, Singh C (1999) Analysis of tea shoot catechins: spectrophotometric quantitation and selective visualization on two-dimensional paper chromatograms using diazotized sulfanilamide. J Agric Food Chem 47:1041–1045

    Article  CAS  Google Scholar 

  9. Pariyani R, Ismail IS,, Azam AA, Abas F, Shaari K, Sulaiman MR. (2015) Phytochemical screening and acute oral toxicity study of java tea leaf extracts. BioMed Research International. https://doi.org/10.1155/2015/742420.

  10. Vijayanarayana K, Rodrigues RS, Chandrashekhar KS, Subrahmanyam EV (2007) Evaluation of estrogenic activity of alcoholic extract of rhizomes of Curculigo orchioides. J Ethnopharmacol 1:241–245

    Article  Google Scholar 

  11. Sulaiman CT, Balachandran I (2016) LC/MS characterization of phenolic antioxidants of Brindle berry (Garcinia gummi-gutta (L.) Robson). Natural Product Res 31:1191–1194

    Article  Google Scholar 

  12. Sulaiman CT, Arun A, Anandan EM, Sandhya CR, Balachandran I (2015) Isolation and identification of phytoestrogens and flavonoids in an Ayurvedic proprietary medicine using chromatographic and mass spectroscopic analysis. Asian Pac J Reprod. 4:153–156

    Article  Google Scholar 

  13. Mena P, Cirlini M, Tassotti M, Herrlinger KA, Asta CD, Rio DD (2016) Phytochemical profiling of flavonoids, phenolic acids, terpenoids, and volatile fraction of a rosemary (Rosmarinus officinalis L.) extract. Molecules. 21:1576

    Article  Google Scholar 

  14. Sulaiman CT, Balachandran I (2016) LC/MS characterization of antioxidant flavonoids from Tragia involucrata L. Beni-Suef University. J Basic Appl Sci 5:231–235

    Google Scholar 

  15. Lakmichi H, Bakhtaoui FZ, Gadhi CA, Ezoubeiri A, Jahiri YE, Mansouri AE, Zrara I, Loutfi K (2011) Evidence-based complementary and alternative medicine. https://doi.org/10.1155/2011/317090

  16. Singh S, Krishna TH, Kamalraj S, Kuriakose GC, Valayil JM, Jayabaskaran C (2015) Phytomedicinal importance of Saraca asoca (Ashoka): an exciting past, an emerging present and a promising future. Curr Sci. 109:1790–1801

    Article  CAS  Google Scholar 

  17. Senapati SK, Das GK, Aparajita S, Rout GR (2012) Assessment of genetic variability in the Asoka tree of India. Biodiversity. 13:16–23

    Article  Google Scholar 

  18. Wen-Lung K, Yu-Ling H, Shr-Ting W, Ching-Li N, Bor-Jinn S, Chien-Chih C (2007) Chemical constituents of Trema orientalis. J Chin Med 18:27–36

    Google Scholar 

  19. Sulaiman CT, Balachandran I (2012) Total phenolics and total flavonoids in selected Indian medicinal plants. Indian J Pharm Sci.: 74; 258–260.

  20. Kowalczyk D, Świeca M, Cichocka J, Gawlik-Dziki U (2013) The phenolic content and antioxidant activity of the aqueous and hydroalcoholic extracts of hops and their pellets. J Inst Brew. 119:103–110

    CAS  Google Scholar 

  21. Kuruto-Niwa R, Inoue S, Ogawa S, Muramatsu M, Nozawa R (2000) Effects of tea catechins on the ERE-regulated estrogenic activity. J Agric Food Chem. 48:6355–6361

    Article  CAS  Google Scholar 

  22. Breinholt V, Hossaini A, Svendsen GW, Brouwer C, Nielsen E (2000) Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability. Food Chem Toxicol. 38:555–564

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors are thankful to Dr. T K Praveen, Department of Pharmacology, JSS College of Pharmacy, Ooty, Tamil Nadu, India, for his support in Pharmacological studies. The authors are thankful to the National Medicinal Plants Board, Ministry of AYUSH, Government of India, for financial assistance (Project # R&D/KE-01/2015-16).

Details of plant sources

Saraca asoca (Roxb.) Wild: Herb garden, Arya Vaidya Sala, Kottakkal, Kerala, India (Voucher specimen No: CMPR 11252)

Polyalthia longifolia (Sonn.) Thwaites: Herb garden, Arya Vaidya Sala, Kottakkal, Kerala, India (Voucher specimen No: CMPR 11253)

Shorea robusta Gaertn: Chattisgarh: (Voucher specimen No: CMPR 11255)

Trema orientalis (L.) Blume: Herb garden, Arya Vaidya Sala, Kottakkal, Kerala, India (Voucher specimen No: CMPR 11251)

Funding

The entire work was financially supported by National Medicinal Plants Board (NMPB), Ministry of AYUSH, Government of India (grant number R&D KE-01/2015-16)

Author information

Authors and Affiliations

  1. Phytochemistry Division, Centre for Medicinal Plants Research, Arya Vaidya Sala, Kottakkal, Malappuram, Kerala, 676503, India

    Sulaiman C. T., Jyothi C. K., Jinu Krishnan Unnithan G., Prabhukumar K.M. & Indira Balachandran

Authors
  1. Sulaiman C. T.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jyothi C. K.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jinu Krishnan Unnithan G.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prabhukumar K.M.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Indira Balachandran
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors have read and approved the manuscript. SCT designed and executed the work, LC/MS analysis, and pharmacological evaluation and drafted the manuscript. JCK participated in extraction, HPTLC analysis, and estimations. JKU participated in extraction, HPTLC analysis, and estimations. PKM collected the plant materials. IB participated in planning and edited the manuscript.

Corresponding author

Correspondence to Sulaiman C. T..

Ethics declarations

Ethics approval and consent to participate

The experimental procedures relating to the animals were authorized by Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) (approval no. JSSCP/IAEC/OT/Ph.D/Ph.Cology/05/2017-18)

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

C. T., S., C. K., J., G., J. et al. Identification of validated substitute for Asoka (Saraca asoca (Roxb.) Willd.) by phytochemical and pharmacological evaluations. Futur J Pharm Sci 6, 10 (2020). https://doi.org/10.1186/s43094-020-00024-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43094-020-00024-2

Keywords

  • Asoka
  • HPTLC
  • HPLC
  • LC/MS
  • Estrogenic activity